3655 results for «215»

Filter By

3655 results

Valve-in-valve - LIVE case

21 Sep 2023 – From AICT-AsiaPCR 2023

An 84-year-old man, with a history of 23 Carpentier-Edwards in 2004, PPM in 2013, AF on warfarin and impaired LV function (40 %), presented with severe symptomatic stenosis of the surgical bioprosthesis.

A 23 Navitor was implanted without predilatation and with post-dilatation under cerebral protection (Sentinel).

Closure was...

Valve-in-valve- AICT-AsiaPCR 2023

Calcified bifurcation lesion - LIVE case

22 Sep 2023 – From AICT-AsiaPCR 2023

A 59-year-old female patient with type 2 DM, dyslipidaemia, hypothyroidism and impaired LV function (39%) presented with multivessel disease. RCA PCI was performed 3 days ago. 

The prox and mid LAD showed a severe calcified lesion including the diagonal. The lesion was prepared using a 1.25 Rotaglide™ ('single-person'...

Calcified bifurcation lesion - LIVE case

Complex CTO - LIVE case

22 Sep 2023 – From AICT-AsiaPCR 2023

View the case of an 82-year-old man with history of CABG in 2003 (LIMA LAD, VG RCA, VG CX), PCIs on VG RCA in 2021, PCIs VG-CX in 2022, PPM in 2023 with preserved LV function, and follow the retrograde approach of calcified CX CTO using...

Complex CTO - LIVE case

AICT-AsiaPCR 2023 Awards Ceremony

22 Sep 2023 – From AICT-AsiaPCR 2023

With a record number of abstracts and clinical cases submitted this year, the winners of these AICT-AsiaPCR 2023 awards have done an excellent job, as the selection process was extremely rigorous. Find out more about the finalists, their reactions and the works that led them to...

AICT-AsiaPCR 2023 Awards Ceremony

AICT-AsiaPCR 2023 Closing Ceremony

22 Sep 2023 – From AICT-AsiaPCR 2023

As AICT-AsiaPCR 2023 draws to a close, it's time to say thank you to the 950 participants and all those who helped make the conference a success, both on stage and behind the scenes.

AICT-AsiaPCR 2023 Closing Ceremony

Revolutionising coronary calcium treatment: unleashing the potential of intravascular lithotripsy

21 Sep 2023 – From AICT-AsiaPCR 2023

Over the last five years, we have learned that there is a new tool for treating calcium, the greatest enemy of interventional cardiology, which can take various forms: intravascular lithotripsy. In this session, look at how to master this technique in different scenarios, from eccentric calcified...

Revolutionising coronary

A hybrid approach in complex PCI: can DES and DCB be complementary?

21 Sep 2023 – From AICT-AsiaPCR 2023

Watch this case-based session to follow discussion about how to choose between DES & DCB,  how both can be complementary in diffuse disease as well as in complex PCI, and how physiology and imaging can help guiding PCI, and follow a patient's treatment live.

A hybrid approach in

Leave nothing behind: DCB-only PCI strategy - How DCB evidence has changed today's practice?

22 Sep 2023 – From AICT-AsiaPCR 2023

This session offers an opportunity to stay informed about the recent developments in the International DCB Consensus Group, gain insights into the latest clinical data and real-world experiences related to drug-coated balloon (DCB)-only PCI, understand the safety aspects of DCB in managing complex PCI cases, and...

Leave nothing behind DCB-only PCI strategy evidence changed today practice

iFR-SWEDEHEART: iFR vs FFR-Guided Coronary Revascularisation

04 Nov 2021

Nicola Ryan reviews the iFR Swedeheart multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) for enrolment randomisation and follow up. At one year follow up iFR guided revascularisation was shown to be non-inferior to FFR guided revascularisation, these results...

Nicola Ryan

Author

Nicola Ryan
iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

Why hypertension is a major unresolved problem

02 Oct 2024

Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.

Sofie Brouwers

Author

Sofie Brouwers
Why hypertension is a major unresolved problem

MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.

15 May 2024

OCT insights of thrombus extraction by stent-retriever thrombectomy (SRT) and manual aspiration (MA): Insights from RETRIEVE AMI trial

29 Oct 2025

Aaysha Cader provides her take on sub-analyses of the RETRIEVE AMI trial presented by Jason Leo Walsh at TCT 2025, in San Francisco.

Author

Aaysha Cader
RETRIEVE AMI: OCT insights of SRT and MA

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

03 Sep 2025

Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author

Aaysha Cader
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

Coronary OCT and CMR imaging to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries

29 Mar 2026

Nicola Ryan provides her take on the trial evaluating multi-modality imaging to determine underlying causes of MINOCA in women and men. The trial results were presented by Harmony R. Reynolds at ACC.26 in New Orleans and simultaneously published in Circulation.

Nicola Ryan

Author

Nicola Ryan
Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

31 Aug 2021

Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.

Daniele Giacoppo

Author

Daniele Giacoppo
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
Didn’t find what you were looking for?